These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28961669)

  • 1. An Unusual Case of Acute Psychosis With Obsessive-Compulsive Features Following Arsenic Poisoning.
    Wu HE; Abdel-Gawad NM; Gharbaoui Y; Teixeira AL; Pigott TA
    J Psychiatr Pract; 2017 Sep; 23(5):382-385. PubMed ID: 28961669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obsessive-compulsive disorder due to neuroacanthocytosis treated with citalopram. A case report.
    Habermeyer B; Fuhr P; Hiss B; Alber C; Müller-Spahn F
    Pharmacopsychiatry; 2006 Sep; 39(5):193-4. PubMed ID: 16944412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obsessive--compulsive disorder and psychosis.
    Ganesan V; Kumar TC; Khanna S
    Can J Psychiatry; 2001 Oct; 46(8):750-4. PubMed ID: 11692979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Misdiagnosis and exacerbation of unusual obsessive-compulsive disorder presentation with risperidone and clozapine in an adolescent girl - A case report.
    Marsanić VB; Aukst-Margetić B; Grgić N; Kusmić E
    Coll Antropol; 2011 Jan; 35 Suppl 1():293-6. PubMed ID: 21648350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and treatment of a patient with both psychotic and obsessive-compulsive symptoms.
    Rodriguez CI; Corcoran C; Simpson HB
    Am J Psychiatry; 2010 Jul; 167(7):754-61. PubMed ID: 20595428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case report of risperidone-induced obsessive-compulsive symptoms.
    Alzaid K; Jones BD
    J Clin Psychopharmacol; 1997 Feb; 17(1):58-9. PubMed ID: 9004062
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effectiveness and tolerability of addition of risperidone in obsessive-compulsive disorder with poor response to serotonin reuptake inhibitors].
    Arias Horcajadas F; Soto JA; García-Cantalapiedra MJ; Rodríguez Calvin JL; Morales J; Salgado M
    Actas Esp Psiquiatr; 2006; 34(3):147-52. PubMed ID: 16736387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexistent hypothyroidism, psychosis, and severe obsessions in an adolescent: a 10-year follow-up.
    Bhatara V; Alshari MG; Warhol P; McMillin JM; Bhatara A
    J Child Adolesc Psychopharmacol; 2004; 14(2):315-23. PubMed ID: 15319028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escitalopram in the treatment of patients with schizophrenia and obsessive-compulsive disorder: an open-label, prospective study.
    Stryjer R; Dambinsky Y; Timinsky I; Green T; Kotler M; Weizman A; Spivak B
    Int Clin Psychopharmacol; 2013 Mar; 28(2):96-8. PubMed ID: 23211492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series.
    Weiss EL; Potenza MN; McDougle CJ; Epperson CN
    J Clin Psychiatry; 1999 Aug; 60(8):524-7. PubMed ID: 10485634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical features of patients with obsessive-compulsive disorder showing different pharmacological responses].
    Sumitani S; Ueno S; Ishimoto Y; Taniguchi T; Tomotake M; Motoki I; Yamauchi K; Ohmori T
    Seishin Shinkeigaku Zasshi; 2006; 108(12):1282-92. PubMed ID: 17334085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hallucinations and obsessive behaviour in an infant with autism spectrum disorder: diagnostic problems].
    Devriese J; Dhar M; Walleghem D; van West D
    Tijdschr Psychiatr; 2015; 57(8):608-12. PubMed ID: 26402898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential response of psychotic and obsessive symptoms to risperidone in an adolescent.
    Dryden-Edwards RC; Reiss AL
    J Child Adolesc Psychopharmacol; 1996; 6(2):139-45. PubMed ID: 9231306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder.
    McDougle CJ; Epperson CN; Pelton GH; Wasylink S; Price LH
    Arch Gen Psychiatry; 2000 Aug; 57(8):794-801. PubMed ID: 10920469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of the use of risperidone, paliperidone and aripiprazole as augmenting agents for obsessive-compulsive disorder.
    Brakoulias V; Stockings E
    Expert Opin Pharmacother; 2019 Jan; 20(1):47-53. PubMed ID: 30360669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and correlates of electroconvulsive therapy delivery in 1001 obsessive-compulsive disorder outpatients.
    Dos Santos-Ribeiro S; Lins-Martins NM; Frydman I; Conceição do Rosário M; Ferrão YA; Shavitt RG; Yücel M; Miguel EC; Fontenelle LF
    Psychiatry Res; 2016 May; 239():145-8. PubMed ID: 27137976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obsessive-compulsive and panic symptoms in patients with first-admission psychosis.
    Craig T; Hwang MY; Bromet EJ
    Am J Psychiatry; 2002 Apr; 159(4):592-8. PubMed ID: 11925297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.
    Simpson HB; Foa EB; Liebowitz MR; Huppert JD; Cahill S; Maher MJ; McLean CP; Bender J; Marcus SM; Williams MT; Weaver J; Vermes D; Van Meter PE; Rodriguez CI; Powers M; Pinto A; Imms P; Hahn CG; Campeas R
    JAMA Psychiatry; 2013 Nov; 70(11):1190-9. PubMed ID: 24026523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risperidone and haloperidol augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder: a crossover study.
    Li X; May RS; Tolbert LC; Jackson WT; Flournoy JM; Baxter LR
    J Clin Psychiatry; 2005 Jun; 66(6):736-43. PubMed ID: 15960567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
    Bloch MH; Landeros-Weisenberger A; Kelmendi B; Coric V; Bracken MB; Leckman JF
    Mol Psychiatry; 2006 Jul; 11(7):622-32. PubMed ID: 16585942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.